naion and tirzepatide Semaglutide use in patients with diabetes was associated with an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) at 2, 3, 4 years. https://ja.ma/4iZkMeV Although rare, GLP-1s tied to

This neurological shift makes calorie reduction feel less forced and more sustainable

Consult a licensed clinician for current guidance on the legal status of compounded medications

But thanks in-part to that off-label prescribing, as well as the Novo Nordisks prioritisation of its weight-loss medication Wegovy, which uses the same active ingredient, the world is suffering a severe shortage of semaglutide expected to last well into next year

For type 2 diabetes (NICE NG28), GLP-1 receptor agonists are generally considered after metformin-based therapy has proven insufficient, and can be initiated in primary care according to local formularies and prescribing arrangements

For your convenience, we recommend wearing comfortable clothing that allows easy access to the injection site, typically the upper arm or buttock